Marking three years of the National Diagnostics Catapult (NDxC), the conclave launched the Impact Report and unveiled environmental surveillance kits
This achievement validates global demand and catapults Wanbury into high-growth acceleration
The Union Budget makes a clear and timely choice by placing biopharma at the centre of India’s next manufacturing wave
The acquisition is a crucial step in LTS' strategy to broaden its portfolio of drug delivery platforms.
The consideration includes Rs. 115 crore (on the date of signing) of cash and cash equivalents in the acquired business indicating an Enterprise Value of Rs. 1,885 crore
New product line to address the challenge of restrictions on use of plastic straws
This year, the company plans to set up more than 200 labs and 3000 collection centres across the world and has ended FY 21 with a revenue of Rs 800 crores
Subscribe To Our Newsletter & Stay Updated
